Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-033769

SVP & Chief Financial Officer sold 3,179 shares at $19.55 ($62,149)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP & Chief Financial Officer 2017-05-16 Sale −3,179 $19.55 $62,149 66,091 D
Open-market sales · 3,179 sh · avg $19.55 · $62,149
Loading xslF345X03/doc4.xml…